Association Between Anti-cyclic Citrullinated Peptide (CCP) Antibody Titers and Oral Prednisolone Tapering in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Cohort Study on Methotrexate Efficacy
| Author | Mohammadhadi Feghhi | en |
| Author | Zohreh Nobakht | en |
| Author | Zahra Mostafavian | en |
| Author | Abbas Mohammadi | en |
| Orcid | Zahra Mostafavian [0000-0002-5738-5605] | en |
| Issued Date | 2025-08-31 | en |
| Abstract | Background: This study examined the association between baseline anti-cyclic citrullinated peptide (anti-CCP) titers and oral prednisolone tapering in patients with newly diagnosed rheumatoid arthritis (RA), emphasizing methotrexate (MTX) efficacy. Methods: A retrospective cohort of 230 RA patients from Mashhad, Iran (2019 - 2021) was stratified by prednisolone use (reduction/discontinuation vs. stable) and anti-CCP titers [high: > 3 × upper limit of normal (ULN); low: 1 - 3 × ULN; normal: ≤ 1 × ULN]. The MTX dose was 10 - 15 mg/week. C-reactive protein (CRP) was measured via immunoturbidimetry. Logistic regression was used to assess the relationship between anti-CCP titers and prednisolone reduction/discontinuation, adjusting for potential confounders such as age, sex, and medication use. A P-value < 0.05 was considered statistically significant. Results: 36.5% (84/230) of patients reduced/discontinued prednisolone. The MTX users had higher odds [odds ratio (OR): 3.022, 95% CI: 1.82 - 5.01, P < 0.001]. No association with anti-CCP titer was observed (P = 0.484). However, logistic regression revealed that patients using MTX (as the reference group) had a significantly higher likelihood of reducing/discontinuing prednisolone (OR: 3.022, P < 0.001). Conclusions: This study found no significant relationship between baseline anti-CCP titers and the reduction/discontinuation of prednisolone in RA patients after 18 months of follow-up. However, MTX use was independently associated with a higher likelihood of reducing or discontinuing prednisolone, suggesting potential implications for treatment strategies in RA management. | en |
| DOI | https://doi.org/10.5812/jjnpp-164624 | en |
| Keyword | Rheumatoid Arthritis | en |
| Keyword | Anti-cyclic Citrullinated Peptide Antibody | en |
| Keyword | Prednisolone | en |
| Keyword | Methotrexate | en |
| Keyword | Cohort Study | en |
| Publisher | Brieflands | en |
| Title | Association Between Anti-cyclic Citrullinated Peptide (CCP) Antibody Titers and Oral Prednisolone Tapering in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Cohort Study on Methotrexate Efficacy | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jjnpp-20-3-164624-publish-pdf.pdf
- Size:
- 338.09 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF